Cytoplasmic localization of NURR1 is associated with decreased patient survival in bladder cancer patients while expression of NURR1 allowed HeLa retrovertant cell lines to regain tumorigenicity[19,20]. Here, NR4A2 is linked to urinary bladder carcinoma.